Patent details

EP0941344 Title: HUMANIZED ANTI-CD11a ANTIBODIES

Basic Information

Publication number:
EP0941344
PCT Application Number:
PCT/US/1997/019041
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP979128410
PCT Publication Number:
WO/1998/023761
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMANIZED ANTI-CD11a ANTIBODIES
French Title of Invention:
ANTICORPS ANTI-CD11a HUMANISES
German Title of Invention:
HUMANISIERTE ANTI-KOERPER GEGEN CD11A
SPC Number:
91122

Dates

Filing date:
20/10/1997
Grant date:
19/05/2004
EP Publication Date:
19/05/2004
PCT Publication Date:
04/06/1998
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/09/1999
EP B1 Publication Date:
19/05/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/10/2017
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/10/1997
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/07/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
JARDIEU Paula, M.
Address:
United States (US)

2

Name:
PRESTA Leonard, G.
Address:
United States (US)

Priority

Priority Number:
757205
Priority Date:
27/11/1996
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/62;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/10/2016
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages